drugset / Trial / NCT03568643

Azithromycin for Uncomplicated Severe Acute Malnutrition in Burkina Faso (Pilot)

NCT03568643

RandomizedParallel-groupSingle-blindTreatment

Summary

This pilot study is a randomized controlled trial designed to test the effect of the administration of adjunctive azithromycin in conjunction with standard outpatient treatment for uncomplicated severe acute malnutrition (SAM) in children aged 6-59 months. Children presenting to nutritional programs in Burkina Faso who meet eligibility criteria will be randomized to a single dose of oral azithromycin or a 7-day course of amoxicillin (standard of care) upon admission into the program. All enrolled children will receive ready-to-use therapeutic foods (RUTF). Enrolled children will be followed at each weekly clinic follow-up visit up to 8 weeks following admission. Data on anthropometric indicators, vital status, and adverse events will be collected during follow-up. Nutritional recovery over the 8-week study period will be compared by arm.

Timeline

Start
2020-06-03
Primary completion
2020-12-25
Completion
2020-12-25

Drugs

EvaluationDrugModalityDoseRoute
Comparator Amoxicillin Other / unclassified 50 mg/kg Oral
Comparator Amoxicillin Other / unclassified 100 mg/kg Oral
Subject Azithromycin Small molecule 20 mg/kg Oral

Indications

No indication recorded.